Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| United Arab Emirates | $1.5M | 95.2% |
| Switzerland | $54.6K | 3.4% |
| Russia | $18K | 1.1% |
| Bangladesh | $5K | 0.3% |
| France | $302 | 0.0% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Bangladesh | $5 | 100.0% |
| Year | Export value |
|---|---|
| 2021 | $17.8K |
| 2022 | $54.5K |
| 2023 | $5 |
| 2024 | $833 |
| 2025 | $1.5M |
| 2026 | $5K |
China customs reports HS 300331 at the 8-digit level. 1 subheading is published under it, and export values for each are available on request.
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300331 is also written 3003.31. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk insulin-containing pharmaceutical products traded for further manufacturing or repackaging, specifically excluding formulations packaged in retail-ready containers or individual pre-measured doses. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments containing insulin (HS 300331) Export Data." https://chinadata.live/china-trade/hs/300331/
HS 300331 is also written 3003.31. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk insulin-containing pharmaceutical products traded for further manufacturing or repackaging, specifically excluding formulations packaged in retail-ready containers or individual pre-measured doses. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments containing insulin (HS 300331) Export Data." https://chinadata.live/china-trade/hs/300331/
China exported $1.6M of medicaments containing insulin in the twelve months to March 2026, averaging $134K per month, based on official China customs statistics (HS 300331).
Bulk insulin-containing pharmaceutical products traded for further manufacturing or repackaging, specifically excluding formulations packaged in retail-ready containers or individual pre-measured doses.
United Arab Emirates, Switzerland and Russia together account for 100% of the published total.
Annual exports grew by 8579% between 2021 and 2025, from $17.8K to $1.5M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.